Board meeting on 29 Oct 2026 to consider Q2 FY26 results and interim dividend

Results View source PDF Explain this filing

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹2877.00

prior close

₹2898.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%+1.0% vs market

Pharmaceuticals peers, median of 172sector-1.7%+0.0% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.7

15m

-0.8

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6-2.6+1.0-1.7+0.0

Next day

-2.1-3.6+1.5-2.2+0.1

-3.5-5.8+2.3-3.4-0.1

-0.9-5.5+4.6-2.4+1.5

+7.4pendingpending-1.2+8.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sanofi India Limited's Board will meet on 29 October 2026 to consider and approve unaudited financial results for Q2 and the nine months ending 30 September 2026. It will also consider declaring an interim dividend for FY2026, if any. The trading window remains closed until 48 hours after the results are announced.

Likely market impact

Potential interim dividend declaration could be positive for shareholders. Q2 results will offer insight into revenue and profit trends.